ARK Invest reshuffles technology and biotech holdings, buying Meta and Cerebras

  • ARK Invest bought Meta, Cerebras, Archer and biotechnology shares while selling Alphabet, AMD, Palantir and Tempus AI.
  • The firm bought 43,091 Meta shares for approximately $28.1 million and 93,290 Cerebras shares for about $17.2 million.
  • Cerebras reported second-quarter revenue of $209.9 million, up 103% year over year, while Meta and Alphabet trades reflected contrasting AI-investment considerations.

ARK Invest made broad portfolio adjustments on September 9, 2026, and in related Wednesday trades, buying Meta Platforms, Cerebras Systems, Archer Aviation and biotechnology companies while selling Alphabet, Advanced Micro Devices, Palantir Technologies, Tempus AI and other holdings. The reported purchases included 43,091 Meta shares worth approximately $28.1 million and 93,290 Cerebras shares valued at about $17.2 million, while sales included 84,392 Alphabet Class A shares worth approximately $27.9 million, 19,491 AMD shares worth $9.9 million and 38,395 Palantir shares worth $6.5 million.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.